Artrya Ltd has released a press release.
Updated Appendix 4C for Q4 FY22
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Artrya
- Quarterly Activity Report and Appendix 4C for Q4 FY22
- Update on US FDA Application for Artrya Salix
- Artrya Signs First U.S. Hospital Clinical Partnership
- Application for quotation of securities - AYA
- Quarterly Activity Report and Appendix 4C for Q3 FY22
Later from Artrya
- Appendix 4E and Annual Financial Report 30 June 2022
- Artrya Successful in Gaining European Regulatory Approval
- Artrya Gains UK Regulatory Approval
- Appendix 4D and Half Year Financial Report
- Board and Management Changes
Follow Artrya into a list and get an email when it puts out news.
Follow Artrya